» Articles » PMID: 34366689

Artificial Intelligence: Potential Tool to Subside SARS-CoV-2 Pandemic

Overview
Journal Process Biochem
Specialty Biochemistry
Date 2021 Aug 9
PMID 34366689
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Artificial intelligence (AI), a method of simulating the human brain in order to complete tasks in a more effective manner, has had numerous implementations in fields from manufacturing sectors to digital electronics. Despite the potential of AI, it may be obstinate to assume that the person administered society would rely solely on AI; with an example being the healthcare field. With the ever-expanding discoveries made on a regular basis regarding the growth of various diseases and its preservations, utilizing brain power may be deemed essential, but that doesn't leave AI as a redundant asset. With the years of accumulated data regarding patterns and the analysis of various medical circumstances, algorithms can be formed, which could further assist in situations such as diagnosis support and population health management. This matter becomes even more relevant in today's society with the currently ongoing COVID-19 pandemic by SARS-CoV-2. With the uncertainty of this pandemic from strain variants to the rolling speeds of vaccines, AI could be utilized to our advantage in order to assist us with the fight against COVID-19. This review briefly discusses the application of AI in the COVID-19 situation for various health benefits.

Citing Articles

Recent advances in the exploration and discovery of SARS-CoV-2 inhibitory peptides from edible animal proteins.

Kong X, Wang W, Zhong Y, Wang N, Bai K, Wu Y Front Nutr. 2024; 11:1346510.

PMID: 38389797 PMC: 10883054. DOI: 10.3389/fnut.2024.1346510.


Diagnostic techniques for critical respiratory infections: Update on current methods.

Zhao L, Wu L, Xu W, Wei J, Niu X, Liu G Heliyon. 2023; 9(8):e18957.

PMID: 37600408 PMC: 10432708. DOI: 10.1016/j.heliyon.2023.e18957.


Artificial intelligence and discrete-event simulation for capacity management of intensive care units during the Covid-19 pandemic: A case study.

Ortiz-Barrios M, Arias-Fonseca S, Ishizaka A, Barbati M, Avendano-Collante B, Navarro-Jimenez E J Bus Res. 2023; 160:113806.

PMID: 36895308 PMC: 9981538. DOI: 10.1016/j.jbusres.2023.113806.


A study on the processing technology for Rhizoma Coptidis.

Wang Y, Qin W, Yang Y, Bai H, Wang J, Zhang X BMC Biotechnol. 2022; 22(1):3.

PMID: 35031033 PMC: 8760793. DOI: 10.1186/s12896-021-00731-5.


The Impact of the Integrated Development of AI and Energy Industry on Regional Energy Industry: A Case of China.

Dong F, Zhang S, Zhu J, Sun J Int J Environ Res Public Health. 2021; 18(17).

PMID: 34501536 PMC: 8431408. DOI: 10.3390/ijerph18178946.

References
1.
Exarchos K, Goletsis Y, Fotiadis D . Multiparametric decision support system for the prediction of oral cancer reoccurrence. IEEE Trans Inf Technol Biomed. 2011; 16(6):1127-34. DOI: 10.1109/TITB.2011.2165076. View

2.
Apostolopoulos I, Mpesiana T . Covid-19: automatic detection from X-ray images utilizing transfer learning with convolutional neural networks. Phys Eng Sci Med. 2020; 43(2):635-640. PMC: 7118364. DOI: 10.1007/s13246-020-00865-4. View

3.
Zang Q, Mansouri K, Williams A, Judson R, Allen D, Casey W . In Silico Prediction of Physicochemical Properties of Environmental Chemicals Using Molecular Fingerprints and Machine Learning. J Chem Inf Model. 2016; 57(1):36-49. PMC: 6131700. DOI: 10.1021/acs.jcim.6b00625. View

4.
Choudhury A, Perumalla S . Detecting breast cancer using artificial intelligence: Convolutional neural network. Technol Health Care. 2020; 29(1):33-43. DOI: 10.3233/THC-202226. View

5.
Afshar P, Heidarian S, Naderkhani F, Oikonomou A, Plataniotis K, Mohammadi A . COVID-CAPS: A capsule network-based framework for identification of COVID-19 cases from X-ray images. Pattern Recognit Lett. 2020; 138:638-643. PMC: 7493761. DOI: 10.1016/j.patrec.2020.09.010. View